Company / PP&E per Share
AGIOS PHARMACEUTICALS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.19
FY2025
5-year range
$0.19 / $0.48
FY2021-FY2025
Trend
-9.7%
vs FY2024
Sector context
#84 of 191
Health Care
What the data says
At $0.19, AGIOS PHARMACEUTICALS, INC.'s pp&e per share ranks #84 of 191 in the Health Care sector. PP&E per Share has declined for 4 consecutive years, from $0.48 in FY2021 to $0.19 in FY2025.
Based on SEC 10-K filings.
0.19 in FY2025 with a 5-year CAGR of -16.8%.
Declined from $0.28 to $0.19 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -23.6%
- 5-Year CAGR
- -16.8%
- 10-Year CAGR
- -
Sector benchmark
#84 of 191 in Health CareTop 44% of 191This company $0.19 Sector average $18.90
▼
-99.0% below sector average
Key checks
Key Insights
- AGIOS PHARMACEUTICALS, INC.'s pp&e per share has declined for 4 consecutive years.
- In FY2025, pp&e per share decreased 9.7% year-over-year.
- Ranks #84 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | -9.7% |
| FY2024 | $0.21 | -25.3% |
| FY2023 | $0.28 | -33.9% |
| FY2022 | $0.42 | -11.6% |
| FY2021 | $0.48 | +1.4% |
| FY2020 | $0.47 | -12.7% |
| FY2019 | $0.54 | +8.5% |
| FY2018 | $0.50 | -13.9% |
| FY2017 | $0.58 | -13.9% |
| FY2016 | $0.67 | +7.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026